AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 260: E521-E525, 1991;
0193-1849/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moe, O.
Right arrow Articles by Henrich, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moe, O.
Right arrow Articles by Henrich, W. L.

AJP - Endocrinology and Metabolism, Vol 260, Issue 4 E521-E525, Copyright © 1991 by American Physiological Society


ARTICLES

Effects of endothelin on in vitro renin secretion

O. Moe, A. Tejedor, W. B. Campbell, R. J. Alpern and W. L. Henrich
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.

The ability of endothelin-1 (ET-1) to directly inhibit renal renin secretion in the presence of a renin stimulator is unknown, as is the mechanism of action of any renin inhibition. Thus direct effects of ET-1 on renin secretion were investigated in two distinct preparations: rat kidney cortical slices and isolated juxtaglomerular cells (JGC). In rat kidney cortical slices, ET-1 reduced basal renin release by 20 (P less than 0.05) and 44% (P less than 0.005) at 10(-9) and 10(-8) M, respectively. To test the efficacy of ET-1 as a renin inhibitor, experiments were performed in the presence of the renin stimulator isoproterenol (10(-5) M). Addition of isoproterenol to cortical slices increased renin release by 97% (P less than 0.001); ET-1 (10(-8) M) limited this increase in renin release by isoproterenol by 80% (P less than 0.05). Similar effects were observed in JGC as ET-1 (10(-8) M) significantly reduced basal renin secretion by 26% (P less than 0.05). In isolated JGC, isoproterenol increased renin secretion by 151% (P less than 0.001); ET-1 (10(-8) M) significantly reduced this stimulated increase in renin secretion by 68%. The mechanism of renin inhibition was examined by testing the effects of the intracellular calcium buffer 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (BAPTA; 10(-6) M) in JGC. BAPTA alone increased renin secretion in JGC by 116% (P less than 0.01); when the combination of (10(-6) M) BAPTA and ET-1 (10(-8) M) were tested in the JGC, renin secretion still increased significantly (by 78%, P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
M. C. Ortiz-Capisano, P. A. Ortiz, P. Harding, J. L. Garvin, and W. H. Beierwaltes
Adenylyl Cyclase Isoform V Mediates Renin Release From Juxtaglomerular Cells
Hypertension, March 1, 2007; 49(3): 618 - 624.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Ortiz-Capisano, P. A. Ortiz, P. Harding, J. L. Garvin, and W. H. Beierwaltes
Decreased Intracellular Calcium Stimulates Renin Release via Calcium-Inhibitable Adenylyl Cyclase
Hypertension, January 1, 2007; 49(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Hohne, M. O. Krebs, M. Seiferheld, W. Boemke, G. Kaczmarczyk, and E. R. Swenson
Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs
J Appl Physiol, August 1, 2004; 97(2): 515 - 521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Elmarakby, P. Morsing, and D. M. Pollock
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Enalapril attenuates endothelin-1-induced hypertension via increased kinin survival
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1899 - H1903.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi
Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues
Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Wada, T. Tsutamoto, M. Ohnishi, M. Sawaki, D. Fukai, Y. Maeda, and M. Kinoshita
Effects of a Specific Endothelin-Converting Enzyme Inhibitor on Cardiac, Renal, and Neurohumoral Functions in Congestive Heart Failure : Comparison of Effects With Those of Endothelin A Receptor Antagonism
Circulation, February 2, 1999; 99(4): 570 - 577.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. L. Henrich, E. A. McAllister, A. Eskue, T. Miller, and O. W. Moe
Renin Regulation in Cultured Proximal Tubular Cells
Hypertension, June 1, 1996; 27(6): 1337 - 1340.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Schricker, H. Scholz, M. Hamann, M. Clozel, B. K. Kramer, and A. Kurtz
Role of Endogenous Endothelins in the Renin System of Normal and Two-Kidney, One Clip Rats
Hypertension, May 1, 1995; 25(5): 1025 - 1029.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
C. Hohne, W. Boemke, N. Schleyer, R. C. Francis, M. O. Krebs, and G. Kaczmarczyk
Low sodium intake does not impair renal compensation of hypoxia-induced respiratory alkalosis
J Appl Physiol, May 1, 2002; 92(5): 2097 - 2104.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online